» Articles » PMID: 37361102

Pharmacological Prospects of Morin Conjugated Selenium Nanoparticles-Evaluation of Antimicrobial, Antioxidant, Thrombolytic, and Anticancer Activities

Overview
Journal Bionanoscience
Specialty Biotechnology
Date 2023 Jun 26
PMID 37361102
Authors
Affiliations
Soon will be listed here.
Abstract

Abstract: Selenium nanoparticles (SeNPs) have gained wide importance in the scientific community and have emerged as an optimistic therapeutic carrier agent for targeted drug delivery. In the present study, the effectiveness of nano selenium conjugated with Morin (Ba-SeNp-Mo) produced from endophytic bacteria reported in our earlier research was tested against various Gram-positive, Gram-negative bacterial pathogens and fungal pathogens that showed good zone of inhibition against all selected pathogens. Antioxidant activities of these NPs were studied by 1, 1-diphenyl-2- picrylhydrazyl (DPPH), 2,2'-Azino-bis-3-ethylbenzothiozoline-6-sulfonic acid (ABTS), hydrogen peroxide (HO), superoxide (O), and nitric oxide (NO) radical scavenging assays that exhibited dose-dependent free radical scavenging activity with IC values 6.92 ± 1.0, 16.85 ± 1.39, 31.60 ± 1.36, 18.87 ± 1.46, and 6.95 ± 1.27 μg/mL. The efficiency of DNA cleavage and thrombolytic activity of Ba-SeNp-Mo were also studied. The antiproliferative effect of Ba-SeNp-Mo was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in COLON-26 cell lines that resulted in IC value of 63.11 μg/mL. Further increased intracellular reactive oxygen species (ROS) levels up to 2.03 and significant early, late and necrotic cells were also observed in AO/EtBr assay. CASPASE 3 expression was upregulated to 1.22 (40 μg/mL) and 1.85 (80 μg/mL) fold. Thus, the current investigation suggested that the Ba-SeNp-Mo has offered remarkable pharmacological activity.

Graphical Abstract:

Citing Articles

Recent Advancements and Unexplored Biomedical Applications of Green Synthesized Ag and Au Nanoparticles: A Review.

Ahmad S, Ahmad S, Ali S, Esa M, Khan A, Yan H Int J Nanomedicine. 2024; 19:3187-3215.

PMID: 38590511 PMC: 10999736. DOI: 10.2147/IJN.S453775.


Role of Nanoparticle-Conjugates and Nanotheranostics in Abrogating Oxidative Stress and Ameliorating Neuroinflammation.

Patel T, Kevadiya B, Bajwa N, Singh P, Zheng H, Kirabo A Antioxidants (Basel). 2023; 12(10).

PMID: 37891956 PMC: 10604131. DOI: 10.3390/antiox12101877.

References
1.
Hosnedlova B, Kepinska M, Skalickova S, Fernandez C, Ruttkay-Nedecky B, Peng Q . Nano-selenium and its nanomedicine applications: a critical review. Int J Nanomedicine. 2018; 13:2107-2128. PMC: 5901133. DOI: 10.2147/IJN.S157541. View

2.
Drozdov A, Vinogradov V, Dudanov I, Vinogradov V . Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activity. Sci Rep. 2016; 6:28119. PMC: 4913305. DOI: 10.1038/srep28119. View

3.
Guisbiers G, Lara H, Mendoza-Cruz R, Naranjo G, Vincent B, Peralta X . Inhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquids. Nanomedicine. 2016; 13(3):1095-1103. PMC: 5660926. DOI: 10.1016/j.nano.2016.10.011. View

4.
Hariharan S, Dharmaraj S . Selenium and selenoproteins: it's role in regulation of inflammation. Inflammopharmacology. 2020; 28(3):667-695. PMC: 7222958. DOI: 10.1007/s10787-020-00690-x. View

5.
Pucci C, Martinelli C, Ciofani G . Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience. 2019; 13:961. PMC: 6753017. DOI: 10.3332/ecancer.2019.961. View